Michael Tung | IR |
James Schoeneck | Interim CEO & Director |
Peony Yu | Chief Medical Officer |
Christine Chung | SVP, China Operations |
Elias Kouchakji | SVP, Clinical Development, Drug Safety & Pharmacovigilance |
Pat Cotroneo | SVP, Finance & CFO |
Michael Yee | Jefferies |
Geoffrey Porges | SVB Leerink |
Edwin Zhang | Stifel, Nicolaus & Company |
Nirav Shelat | Piper Jaffray Companies |
Paul Choi | Goldman Sachs Group |
Joel Beatty | Citigroup |
Welcome to the FibroGen Third Quarter 2019 Financial Results Conference Call. My name is Erin, and I'll be your operator for today's call.
[Operator Instructions]. Please note that this conference is being recorded. I will now turn the call over to Michael Tung.